Abstract 5577: LSD1 inhibition remodels the tumor microenvironment to enhance anti-PD1 immunotherapy in HNSCC

肿瘤微环境 癌症研究 免疫疗法 免疫系统 头颈部鳞状细胞癌 卵清蛋白 肿瘤进展 细胞 医学 肿瘤抗原 抗原 抗原呈递 脱甲基酶 乙酰化 T细胞 癌症 表观遗传学 化学 联合疗法 癌症免疫疗法 免疫原性细胞死亡 FOXP3型 免疫学 组蛋白 甲基化 细胞疗法 癌
作者
Amit Kumar Chakraborty,Chumki Choudhury,Rajnikant Dilip Raut,Manish V. Bais
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:86 (7_Supplement): 5577-5577
标识
DOI:10.1158/1538-7445.am2026-5577
摘要

Background: The histone demethylase LSD1 (KDM1A), an epigenetic regulator implicated in tumor progression and immune suppression. Programmed cell death protein-1 (PD-1/CD279) marks exhausted CD8+ T cells and binds PD-L1 (CD274) in the tumor epithelium. Anti-PD-1 therapy has limited success in head and neck squamous cell carcinoma (HNSCC). We hypothesized that LSD1 inhibitor (SP2509), due to its specific mechanisms, shows superior anti-cancer activity in combination with anti-PD1 therapy. Methods: We assessed SP2509’s impact on the tumor microenvironment (TME) in a syngeneic 4MOSC1 oral squamous cell carcinoma (OSCC) model and 4NQO-induced progressive OSCC model. Anti-PD-1 monotherapy and anti-PD-1-SP2509 combination therapy were tested in a 4NQO model. Multiple methods like immunostaining, qRT-PCR, flowcytometry were employed to test the hypothesis. Ovalbumin overexpression assay followed by flowcytometry was used to determine the antigen presentation in every groups. ChIP-qPCR was used to determine the H3K4 and H3K9 methylation change status on HLA-A, HLA-B and PD-L1 gene locus. Public RNA-seq data (GSE153383) were analyzed to examine immune cell responses to anti-PD-1 and compared with our findings. Results: SP2509 increased immune cell infiltration, including CD8+ T cells, and reduced the frequency of PD-L1+ epithelial tumor cells in both 4MOSC1 and 4NQO models. Anti-PD-1 monotherapy expanded CD8+ T cells but did not alter PD-L1 + epithelial cells. Each treatment alone enhanced CD8+ T-cell IFN-γ production, consistent with the GSE153383 analysis showing elevated T-cell infiltration and IFN-γ in anti-PD-1 treated samples. Furthermore, we observed a significant increase in antigen presentation in anti-PD-1 and SP2509 combination group with ovalbumin assay. The combination regimen produced greater immune infiltration, particularly CD8+ T-cells with higher IFN-γ levels, a significant reduction in PD-L1+ epithelial cells, and more pronounced tumor regression than anti-PD-1 alone was observed in vivo. ChIP-qPCR results shows increase in H3K4me2 in HLA-A and HLA-B gene locus while H3K9me2 increase in PD-L1 gene locus was observed after SP2509 treatment. We also observed DC activation in SP2509 alona and in combination groups and absent in only anti-PD1 treatment group. Conclusions: Targeting LSD1 with SP2509 enhances the anti-PD-1 efficacy in HNSCC by modulating the TME, augmenting CD8+ T-cell-mediated antitumor immunity and antigen presentation via MHC class I activation, and reducing tumor PD-L1 expression, ultimately leading to a reduction in HNSCC growth. Citation Format: Amit Kumar Chakraborty, Chumki Choudhury, Rajnikant Raut, Manish V. Bais. LSD1 inhibition remodels the tumor microenvironment to enhance anti-PD1 immunotherapy in HNSCC [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 5577.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
Ming完成签到,获得积分10
1秒前
2秒前
11完成签到,获得积分10
2秒前
江添盛望完成签到,获得积分10
2秒前
2秒前
贻嘉完成签到,获得积分10
3秒前
NexusExplorer的应助被Brave采纳,获得10
3秒前
Jin发布了新的文献求助30
3秒前
why完成签到 ,获得积分10
3秒前
忘了去记得完成签到 ,获得积分10
3秒前
小汤圆完成签到,获得积分10
3秒前
zyf发布了新的文献求助10
4秒前
刘彤发布了新的文献求助10
5秒前
娜娜完成签到,获得积分20
5秒前
etheral发布了新的文献求助10
7秒前
111发布了新的文献求助10
7秒前
7秒前
王乐乐发布了新的文献求助10
8秒前
hmj完成签到,获得积分10
8秒前
小马甲的应助被安静季节采纳,获得10
8秒前
Jigsaw发布了新的文献求助10
8秒前
大个的应助被mmmml采纳,获得10
9秒前
10秒前
暮念给暮念的求助进行了留言
10秒前
10秒前
15311533181完成签到,获得积分10
11秒前
vnewgnl的应助被torfun采纳,获得10
11秒前
cookie完成签到,获得积分10
11秒前
Jasper的应助被1123采纳,获得10
11秒前
hahdong完成签到,获得积分10
11秒前
12秒前
ket的应助被火山采纳,获得10
12秒前
12秒前
12秒前
blossem发布了新的文献求助10
14秒前
111发布了新的文献求助20
14秒前
hetaoren完成签到,获得积分10
15秒前
ke完成签到,获得积分20
15秒前
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192078
求助须知:如何正确求助?哪些是违规求助? 9578698
关于积分的说明 21861559
捐赠科研通 7791583
什么是DOI,文献DOI怎么找? 3436814
关于科研通互助平台的介绍 2560538
邀请新用户注册赠送积分活动 2483582